Protein Labeling Market Size Worth $4.11 Billion By 2030: Grand View Research, Inc.

13 Jun 2022
Antibody
SAN FRANCISCO, June 13, 2022 /PRNewswire/ --
The global protein labeling market size is expected to reach USD 4.11 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.6% from 2022 to 2030. The study of Post-translational Modification (PTM) of proteins has gained immense popularity in cell biology and disease treatment and prevention. The introduction of effective quantification methods of protein expression with the use of tagging strategies, such as iodoTMTzero Label Reagent that detects nitrosylation, has driven an efficient determination of PTMs. Therefore, a rise in PTM-related studies is driving the market. The emergence of novel techniques and the launch of improved products are expected to positively influence market growth.
One such development includes the application of new spin labels that expand the capability of site-directed spin labeling of proteins. These labels in combination with electron paramagnetic resonance spectroscopy (SDSL-EPR) enable the investigation of protein structure, dynamics, and structural heterogeneity.
Key Industry Insights & Findings from the report:
Proteins dominated the reagents segment in 2021 as fluorescent proteins are beneficial and allow in situ fusion expression through gene transfer into cells.
This eliminates the need for purification, in vitro labeling, high-level heterologous production, and microinjection of recombinant proteins.
The fluorescence microscopy segment is estimated to register the fastest CAGR from 2022 to 2030 due to the development of monomeric fluorescent proteins that are capable to fluoresce orange to far-red bands of the visible light spectrum.
The in-vitro labeling segment accounted for the largest revenue share in 2021 and is anticipated to witness the fastest CAGR during the forecast period.
The less complexity associated with in-vitro techniques and the availability of a large number of commercial kits for these techniques result in a larger share of the segment in 2021.
North America accounted for the maximum revenue share in 2021 due to the presence of key manufacturers, increase in proteomics research, the advent of bioengineering technologies, and high adoption of these products in disease diagnosis-associated studies.
Get more Insights from 130 page market research report, "Protein Labeling Market Size, Share & Trends Analysis Report By Product (Services, Kits, Reagents), By Application (Fluorescence Microscopy, Cell-based Assays), By Method (In-vitro, In-vivo), And Segment Forecasts, 2022 - 2030", published by Grand View Research.
Protein Labeling Market Growth & Trends
The market is growing as private players and government agencies increased investments in proteomics and genomics R&D. Proteomics is the study of the entire protein content of a cell, tissue, or organism. Proteomic profiling approaches require protein labeling methods before separation and analysis. For example, the United States National Institutes of Health (NIH) allocated USD 37 billion to scientific research.
Moreover, there is an increase in funding for life sciences research that supports molecular studies to better understand the fundamental processes by which diseases emerge, as well as the identification of biomarkers that identify the presence of disease or the gene/protein responsible for the condition. The Novo Nordisk Foundation awarded the University of Copenhagen a grant of up to USD 1.5 million to create a mass spectrometry facility, which is a new and exciting step in protein research. As a result, the market is being driven by increased spending on proteomics and genomics research and development. Protein labeling applications are widely employed for a variety of functions. Cell-based assays can offer information about intracellular molecular targets and have the advantage of being performed in a biological context.
Fluorescent antibodies are important in clinical therapy as well as for investigating immunology, cell biology, and neuroscience. A mass spectrometer is a device that detects the m/z ratio of ions to identify and quantify compounds in simple and complicated mixtures. It has proven indispensable in a variety of domains and applications, including proteomics. Immunological approaches include ways of studying the immune system as well as the application of immunological reagents as instruments. Protein microarrays are a new type of proteomic technology that is rapidly gaining popularity in molecular biology and biochemistry.
Protein Labeling Market Segmentation
Grand View Research has segmented the global protein labeling market on the basis of product, application, method, and region:
Protein Labeling Market - Product Outlook (Revenue, USD Million, 2018 - 2030)
Reagents
Proteins
Enzymes
Probes/Tags
Monoclonal antibodies
Other reagents
Kits
Services
Protein Labeling Market - Application Outlook (Revenue, USD Million, 2018 - 2030)
Cell-based Assays
Fluorescence Microscopy
Protein Microarray
Protein Labeling Market - Method Outlook (Revenue, USD Million, 2018 - 2030)
In-vitro Labeling Methods
Enzymatic methods
Dye-based methods
Co-translational methods
Nanoparticle methods
Others
In-vivo Labeling Methods
Photoreactive methods
Radioactive methods
Others
Protein Labeling Market - Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
China
Japan
Latin America
Brazil
South Africa
List of Key Players in the Protein Labeling Market
Merck KGaA
New England Biolabs
Check out more related studies published by Grand View Research:
Nucleic Acid Labeling Market
- The global nucleic acid labeling market size is expected to reach USD 3.22 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.81% from 2020 to 2027. Technological advancements with respect to PCR, DNA sequencing, nanotechnology, and microfluidics are expected to help enhance the market potential in the near future. Additionally, nucleic acid labeling products are gaining significant momentum across diagnostic as well as therapeutic interventions associated with cancer disorders and genetic deformities, thereby elevating the market growth.
Protein Purification And Isolation Market - The global protein purification and isolation market size is expected to reach USD 19.1 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.6% from 2022 to 2030. Technological advancements and investments for the development of structure-based drugs by both private and public research organizations are driving the demand for protein purification and isolation products.
Biotechnology Reagents & Kits Market - The global biotechnology reagents & kits market size is expected to reach USD 1.14 trillion by 2028, registering a CAGR of 16.5% over the forecast period, according to a new report by Grand View Research, Inc. Key factors driving the market include the introduction of novel and advanced products, a rise in investments in the biotechnology sector, and increasing demand for synthetic biology.
Browse through Grand View Research's
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Grand View Compass | Grand View Pipeline
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.